SCHEMBL18679335

SCHEMBL18679335

Cc1cccc(-c2cc(-c3ccc(-c4ccc(-n5c6ccc(N(c7ccccc7)c7ccccc7)cc6c6cc(N(c7ccccc7)c7ccccc7)ccc65)cc4)cc3C)nc(-c3cccc(C)c3)n2)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.33
NR3C1 P04150 1/20 0.33
NR1I3 Q14994 1/20 0.33
TP53 P04637 1/20 0.32
ENPP3 O14638 2/20 0.32
MEN1 O00255 2/20 0.32
LMNA P02545 2/20 0.32
KMT2A Q03164 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
RAB9A P51151 2/20 0.31
ALDH1A1 P00352 2/20 0.31
NPC1 O15118 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18679258 1.00 MAPT (0.33) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679673 0.97 MAPT (0.34) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679761 0.97 MAPT (0.34) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679255 0.95 ENPP3 (0.33) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679252 0.95 ENPP3 (0.33) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679254 0.95 MAPT (0.34) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679315 0.94 MAPT (0.34) MAPTNR3C1NR1I3TP53MEN1
SCHEMBL18684193 0.94 ENPP3 (0.33) MAPTNR3C1NR1I3TP53ENPP3
SCHEMBL18679369 0.94 MAPT (0.35) MAPTNR3C1NR1I3TP53MEN1
SCHEMBL18679649 0.93 MAPT (0.33) MAPTNR3C1NR1I3TP53ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2020-07-30 US disclosed
US-10651392-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-05-12 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10651392-B2 Organic light-emitting device OR10J3, L1CAM, EML4 MAPT 1197/4885NR3C1 983/4885NR1I3 1347/4885
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 MAPT 1197/4885NR3C1 983/4885NR1I3 1347/4885
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 MAPT 1197/4885NR3C1 983/4885NR1I3 1347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.